The quarter beat, primarily on profit rather than sales. Adjusted EPS of $2.45 exceeded the published consensus of roughly $2.24 and even topped the high end of Celanese's own $2.00-$2.40 outlook. Revenue of $2.75 billion was essentially in line with the roughly $2.75 billion expectation, so the upside came from much stronger margins and execution rather than a surprise in demand. (Adjusted EPS reconciliation; Net Sales table)
| Metric | Q2 2026 | Q1 2026 | Q2 2025 / expectation | Read-through |
|---|---|---|---|---|
| Adjusted EPS | $2.45 | $0.85 | $1.34 / ~$2.24 consensus | Clear earnings beat (Adjusted EPS reconciliation) |
| Net sales | $2.752B | $2.337B | $2.419B / ~$2.75B expected | Essentially in line on revenue (Net Sales table) |
| Adjusted EBIT | $470M | $275M | $326M | Strong sequential and year-over-year margin recovery (Adjusted EBIT by segment) |
| Acetyl Chain adjusted EBIT | $321M | $131M | $187M | Main source of the upside (Adjusted EBIT by segment) |
| Engineered Materials adjusted EBIT | $234M | $220M | $200M | Better earnings, though margin slipped sequentially to 16.2% from 16.6% (Adjusted EBIT by segment) |
| Free cash flow | $140M | $3M | $375M | Cash conversion remained weak versus earnings (Free Cash Flow table) |
| Net debt | $10.643B | $10.796B | $11.414B | Debt is moving down, but remains high (Net Debt table) |
Acetyl Chain supplied the surprise, but management says much of it will fade. Segment adjusted EBIT jumped to $321 million from $131 million in Q1, aided by Western Hemisphere supply disruptions, pricing, volume, and about $40 million of acetate-tow equity income that normally returns after Q1. That was materially stronger than the market appeared to expect, but it is not being presented as a new steady run rate: management guides Acetyl Chain EBIT down to $220-$250 million in Q3 as supply-related pricing and margin opportunities normalize. (Prepared Comments — Acetyl Chain; Q3 Outlook)
The guidance keeps the beat from becoming a broad upgrade. Q3 adjusted EPS guidance of $1.35-$1.75 implies a sharp sequential step-down from $2.45, reflecting fading disruption benefits, higher raw-material costs, and inventory effects from the nylon and Lanaken footprint changes. Full-year adjusted EPS remains about $6.00, rather than rising after the strong Q2 result. In other words, the quarter improves confidence in execution, but does not change the company's full-year earnings destination. (Prepared Comments — Q3 Outlook; Full-Year Outlook)
Cash and leverage remain the limiting issue. Free cash flow was only $140 million despite $470 million of adjusted EBIT, as working capital consumed $178 million; first-half free cash flow totals just $143 million against the retained $700-$800 million full-year target. The company did reduce net debt to $10.643 billion at quarter-end and repaid upcoming 2026 bonds using cash, but achieving the cash target and planned divestitures still matters for the deleveraging case. (Prepared Comments — Cash Flow and Debt Repayment; Free Cash Flow table; Net Debt table)
The cleaner underlying picture is better than GAAP earnings suggest, but adjustments were sizable. GAAP continuing EPS was $1.15, versus adjusted EPS of $2.45, after $156 million of excluded items—mostly $121 million of exit and shutdown costs and $35 million related to mergers, acquisitions, and dispositions. Those restructuring costs are tied to actions intended to lower future costs, but they are real near-term cash and earnings friction while the company works through its footprint changes. (Adjusted EPS reconciliation; Certain Items table)
Read the original 8-K on SEC EDGAR ↗